Most frequently, the oncolytic HSVs are deleted in the neurovirulence gene γ134.5, and gain cancer specificity from the fact that a number of cancer cells are defective in mounting the innate protein kinase R (PKR) response to the virus [3,4]. The gene discussed is EIF2AK2; the disease is cancer.